Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...

but the currently available drug discovery tools are slow and computationally intensive. At Vanderbilt University, Assistant ...

GSK said it is ending the development program for the small-molecule drug Belrestotug. The British pharmaceutical giant said Tuesday that the decision is based on a new interim analyses from phase ...

Currently trailing Eli Lilly and Structure Therapeutics in the oral weight loss space, Novo Nordisk strikes a deal with ...

Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for neurodegenerative conditions like Parkinson's and Alzheimer's. The team has identified a small ...

Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...

Michael Dong recently discussed sample preparation (SP) techniques for small-molecule drug substances and solid dosage forms.

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Just recently Miller-Meeks co-sponsored the Ensuring Pathways for Innovative Cures (EPIC) Act, which is a critical step ...

From my colleague Jason Mast: The first ever patient has been treated with prime editing, a powerful technology for making ...

According to KFF, the new executive order directs the Department of Health and Human Services to work with Congress to implement a change in the Medicare Drug Price Negotiation Program to delay ...